Matching Access with Patient Safety: USAID Funded Programs Partner with the Pharmacy and Poisons Board (PPB)to Enhance Safety and Quality of Medicines in Kenya
Global public health initiatives in developing countries have increased access to medicines including those for HIV/AIDS, Malaria, and Tuberculosis (TB). This access creates the need to systematically monitor and promote the safety and effectiveness of these medicines via national pharmacovigilance programs.
Patient safety remains the core business of any medicines regulatory authority (MRA) across the world. Keeping up with the pace of this mandate in a modern fast-growing world is a challenge for most MRAs in Africa because many developing countries lack the appropriate structures, systems, and resources to systematically support the detection and prevention of adverse drug reactions (ADRs) and other medicine-related problems. This challenge is further complicated by emerging diseases, increasing number of medicines, co-morbidities and health technologies.